Regentis Biomaterials Ltd. (RGNT) Operating cash flow 2023–2025
Regentis Biomaterials Ltd. (RGNT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$1.4MFY2025 · since FY2023: -$1.2M → -$1.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.4M | -114.5% |
| FY2024 | -$641,000 | +47.5% |
| FY2023 | -$1.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice